MAIA Biotechnology MAIA
NYSE MAIA
$1.13 -0.01 (-1.10%)
As of: Oct 22, 2026 · 12:03 PM EDT

MAIA Biotechnology (MAIA) Liabilities and Shareholders Equity (2021 - 2026)

Updated

MAIA Biotechnology's Liabilities and Shareholders Equity came in at $28.24 million for Q2 2026, up 155.7% from $11.05 million a year earlier but down 20.1% from the prior quarter.

Analysis

MAIA Biotechnology (MAIA) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

At the end of FY2025, MAIA Biotechnology's Liabilities and Shareholders Equity was $9.7 million, down 4.4% from FY2024.

  • Liabilities and Shareholders Equity carries a four-year compound annual growth rate of -3.8% (FY2021 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $10.16 million in FY2024 (+34.2%), $7.57 million in FY2023 (-37.1%), $12.02 million in FY2022 (+6.1%) and $11.33 million in FY2021.
  • The five-year range for quarterly Liabilities and Shareholders Equity is $7 million (Q3 2023) to $35.32 million (Q1 2026).
  • Year-over-year, Liabilities and Shareholders Equity increased in six of the last eight quarters, with growth averaging 58.8%.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q1 2026 (growth of 197.7%), and the weakest in Q3 2023 (a decline of 52.6%).
  • Business Quant data shows MAIA's Liabilities and Shareholders Equity at $35.32 million (Q1 2026), $9.7 million (Q4 2025) and $11.78 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,170.57 Bn 1,139.16 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 641.68 Bn 560.21 Bn 17.26 Bn 201.06 Bn
3 AbbVie 502.16 Bn 475.27 Bn 12.70 Bn 135.12 Bn
4 Merck 375.54 Bn 329.92 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 302.70 Bn 266.69 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 268.54 Bn 242.22 Bn 12.86 Bn 115.83 Bn
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 193.36 Bn 167.56 Bn 6.22 Bn 49.36 Bn
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn 201.13 Bn
10 MAIA Biotechnology 68.55 Mn -13.01 Mn - 28.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.24 Mn
Mar 31, 2026 35.32 Mn
Dec 31, 2025 9.70 Mn
Sep 30, 2025 11.78 Mn
Jun 30, 2025 11.05 Mn
Mar 31, 2025 11.86 Mn
Dec 31, 2024 10.16 Mn
Sep 30, 2024 9.24 Mn
Jun 30, 2024 12.02 Mn
Mar 31, 2024 8.72 Mn
Dec 31, 2023 7.57 Mn
Sep 30, 2023 7.00 Mn
Jun 30, 2023 10.27 Mn
Mar 31, 2023 9.07 Mn
Dec 31, 2022 12.02 Mn
Sep 30, 2022 14.78 Mn
Jun 30, 2022 9.76 Mn
Dec 31, 2021 11.33 Mn
API Access

MAIA Biotechnology Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MAIA&period=max&api_key=YOUR_API_KEY